Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Apyx Medical Corporation - Common Stock
(NQ:
APYX
)
1.600
-0.160 (-9.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apyx Medical Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
A Look Ahead: Apyx Medical's Earnings Forecast
November 07, 2024
Via
Benzinga
APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
August 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
August 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
July 25, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical's Earnings: A Preview
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 13, 2024
Via
Benzinga
APYX Stock Earnings: Apyx Medical Misses EPS, Beats Revenue for Q1 2024
May 09, 2024
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
May 09, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces Board Leadership Transition
May 09, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
April 25, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
April 11, 2024
From
Apyx Medical Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results
March 21, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.77% to 39,814.95 while the NASDAQ rose 0.25% to 16,410.54. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 21, 2024
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 21, 2024
Via
Benzinga
Gold Gains 1%; Micron Posts Upbeat Results
March 21, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.84% to 39,844.27 while the NASDAQ rose 0.61% to 16,469.28. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
APYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023
March 21, 2024
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
March 21, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
March 04, 2024
From
Apyx Medical Corporation
Via
Business Wire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
February 21, 2024
From
Apyx Medical Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
January 22, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
January 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
November 28, 2023
From
Apyx Medical Corporation
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 16, 2023
Via
Benzinga
Insiders Buying Apyx Medical And 3 Other Stocks Under $3
November 16, 2023
The Dow Jones closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.